Skip to content

Construction and Evaluation of Traditional Chinese Medicine Chronic Disease Management Model for Gout

Construction and Evaluation of Traditional Chinese Medicine Chronic Disease Management Model for Gout

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071103
Enrollment
Unknown
Registered
2023-05-05
Start date
2023-05-05
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Interventions

Control group:The control group received routine care and medication treatment
Intervention group:the management mode of chronic diseases of gout in traditional Chinese medicine based on routine care.

Sponsors

Yunnan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for primary gout; (2) Meets the diagnostic efficacy criteria for gout in traditional Chinese medicine; (3) The age range of the subjects is between 18 and 65 years old, regardless of gender; (4) Not participating in clinical research, or having stopped medication and eluted for more than 6 months after participating in clinical research; (5) Patients are aware of the significance of participating in this project and the potential adverse reactions that may occur in clinical research, and voluntarily participate.Sign an informed consent form with the study. (6) The patient has a clear consciousness and clear language expression, no mental or neurological diseases and other diseases that hinder psychological test, and can cooperate to complete the investigation. (7) Patients have cognitive abilities, can use smartphones on their own or with the help of others, and can actively cooperate to ensure the continuity of treatment and regular follow-up.

Exclusion criteria

Exclusion criteria: (1) Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney, endocrine, and hematopoietic systems, as well as those with overlapping other rheumatic and immune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, Sjogren's syndrome, etc; (2) Suffering from serious mental illnesses such as schizophrenia and epilepsy or being in critical condition, unable to cooperate in completing clinical observation; (3) Women in pregnancy, lactation, or those in need of pregnancy preparation; (4) Those who plan to undergo surgery in the near future; (5) There are alcoholics, drug users, or drug abusers.

Design outcomes

Primary

MeasureTime frame
UA;rate of hospital admission;the relapse rate of disease;

Secondary

MeasureTime frame
Kidney function test;Liver function test;ESR;CRP;Blood lipid testing;BMI;Routine blood testing;

Countries

China

Contacts

Public ContactPeng Jiangyun

Yunnan Hospital of Traditional Chinese Medicine

pengjiangyun@126.com+86 13099963399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026